OPTIMIzE seeks to understand evolving patterns of care and estimate overall survival rates in patients with unresectable or metastatic Melanoma in the clinical practice setting

Sponsor
Bristol=Myers Squibb

Protocol Number
Nristol Myers Squibb CA209-357 OPTIMIZE

To Learn More Call
201-510-0910